Start-ups to scale manufacturing of stem-cell therapies for practical use
Nature - 29-Sep-2021Challenges of mass producing stem cells and how 3 companies are attempting to overcome them
Join the club for FREE to access the whole archive and other member benefits.
Chief Technology Officer at Advanced Regenerative Manufacturing Institute
Chief Technology Officer at the Advanced Regenerative Manufacturing Institute (ARMI), BioFabUSA. Prior to joining ARMI, Tom served as Vice President of Research and Development at Harvard Apparatus Regenerative Technology. Tom joined the HART from Organogenesis, where he implemented and completed IND-enabling preclinical programs for bioengineered living skin.
Tom received his B.Sc. in Biochemistry from the University of Waterloo, a Ph.D. in Biochemistry from the University of Notre Dame.
Visit website: https://informaconnect.com/cell-therapy-bioprocessing/speakers/thomas-bollenbach/
See also: Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA - BioFabUSA integrates innovative cell and tissue cultures.
Details last updated 26-Oct-2021
Challenges of mass producing stem cells and how 3 companies are attempting to overcome them